Abstract
The increasing interest in the management of osteoporosis has been stimulated by awareness of the socioeconomic cost of osteoporotic fractures, the development of techniques for the diagnosis and monitoring of the condition and the introduction of effective treatments which prevent bone loss and decrease the risk of fractures. The development of dual energy X-ray absorptiometry (DXA) techniques in particular, has allowed the accurate and precise measurement of bone mineral density (BMD) at the major sites of fracture, such as the spine and hip. DXA bone density measurements are therefore being used increasingly for the diagnosis of osteoporosis and monitoring the response to treatment.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ross PD, Davis JW, Epstein RS et al. (1991) Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med 114:919–923.
Peel N (1993) Eastell R. Measurement of bone mass and turnover. Baillieres Clin Rheumat -osteoporosis 7:479–498.
WHO Study Group (1994)Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report. World Health Organization, Geneva.
Peel NF, Moore DJ, Barrington NA et al. (1995) Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann Rheum Dis 54:801–806.
Melton LJ, Chrischilles EA, Cooper C et al. Perspective: how many women have osteoporosis? J Bone Miner Res 7:1005–1010.
Francis RM (1998) Cyclical etidronate in the management of osteoporosis in men. Rev Contemp Pharmacother 9:261–266.
Eastell R, Boyle IT, Compston J et al. (1998) Management of male osteoporosis: report of the UK Consensus Group. Q J Med 91:71–92.
Anderson FH, Francis RM, Selby PL et al. (1998) Sex hormones and osteoporosis in men. Calcif Tissue Int 62:185–188.
Scane AC, Francis RM, Sutcliffe AM et al. (1999) Case-control study of the pathogenesis and sequelae of symptomatic vertebral fractures in men. Osteoporosis Int 9:91–97.
Baillie SP, Davison CE, Johnson FJ et al. (1992) Pathogenesis of vertebral crush fractures in men. Age Ageing 21:139–141.
Francis RM, Peacock M, Marshall DH et al. (1989) Spinal osteoporosis in men. Bone Miner 5:347–357.
Delaet CED, VanHout BA, Burger H et al. (1997) Bone density and risk of hip fracture in men and women: cross-sectional analysis. Br Med J 315:221–225.
Anderson FH, Francis RM, Bishop JC et al. (1997) Effect of intermittent cyclical disodium etidronate therapy on bone mineral density in men with vertebral fractures. Age Ageing 26:359–365.
Scane AC, Francis RM, Johnson FJ et al. (1992) The effects of testosterone treatment in eugonadal men with osteoporosis. In: Ring EFJ. ed. Current research in osteoporosis and bone mineral measurement II: 1992. British Institute of Radiology, London, p. 54.
Anderson FH, Francis RM, Peaston RT et al. (1997) Androgen supplementation in eugonadal men with osteoporosis - effects of six months’ treatment on markers of bone formation and resorption. J Bone Miner Res 12:472–478.
Reid IR, Wattie DJ, Evans MC et al. (1996) Testosterone therapy in glucocorticoid-treated men. Arch Intern Med 156:1173–1177.
Ringe JD, Dorst A, Kipshoven C et al. (1998) Avoidance of vertebral fractures in men with idiopathic osteoporosis by a three year therapy with calcium and low-dose intermittent monofluorophosphate. Osteoporosis Int 8:47–52.
Caplan GA, Scane AC, Francis RM (1994) Pathogenesis of vertebral crush fractures in women. J R Soc Med 87:200–202.
Francis RM, Sutcliffe AM, Scane AC (1998) Pathogenesis of osteoporosis. In: Stevenson JC, Lindsay R (eds) Osteoporosis. Chapman Hall, London, pp. 29–51.
Eastell R, Reid DM, Compston J et al. (1998) UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update. Journal Intern Med 244:271–292.
Reeves HL, Francis RM, Manas DM et al. (1998) Intravenous bisphosphonate prevents symptomatic osteoporotic vertebral collapse in patients after liver transplantation. Liver Transplant Surg 4:404–409.
Boyle IT (1998) Secondary osteoporosis. Bailliere’s Clin Rheumatol - Osteoporosis 7:515–534.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Francis, R.M. (2000). The Use of Bone Density Measurements in Male and Secondary Osteoporosis. In: Fordham, J.N. (eds) Manual of Bone Densitometry Measurements. Springer, London. https://doi.org/10.1007/978-1-4471-0759-0_5
Download citation
DOI: https://doi.org/10.1007/978-1-4471-0759-0_5
Publisher Name: Springer, London
Print ISBN: 978-1-4471-1196-2
Online ISBN: 978-1-4471-0759-0
eBook Packages: Springer Book Archive